HSP90AB1 and hepatocellular carcinoma: Since decreased SREBP1 protein level caused by Hsp90 inhibitors treatments could only be partially reversed by MG132, we next explored whether Hsp90 inhibitors reduced transcripts of SREBP1 in HCC cells.